Jim Birchenough analyst WELLS FARGO

Currently out of the existing stock ratings of Jim Birchenough, 85 are a BUY (66.41%), 39 are a HOLD (30.47%), 4 are a SELL (3.13%).

Jim Birchenough

Work Performance Price Targets & Ratings Chart

Analyst Jim Birchenough, currently employed at WELLS FARGO, carries an average stock price target met ratio of 63.8% that have a potential upside of 39.25% achieved within 283 days.

Jim Birchenough’s has documented 324 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RGLS, Regulus Therapeutics at 13-Mar-2024.

Wall Street Analyst Jim Birchenough

Analyst best performing recommendations are on INFI (INFINITY PHARMACEUTICALS).
The best stock recommendation documented was for BLCM (BELLICUM PHARMACEUTICALS) at 2/14/2020. The price target of $4 was fulfilled within 31 days with a profit of $6.42 (61.61%) receiving and performance score of 19.87.

Average potential price target upside

AKCA Akcea Therapeutics ARNA Arena Pharmaceuticals BLCM Bellicum Pharmaceuticals BLUE Bluebird bio CRSP Crispr Therapeutics AG FATE Fate Therapeutics FPRX Five Prime Therapeutics HALO Halozyme Therapeutics ICPT Intercept Pharmaceuticals IMV IMV . MRNA Moderna QURE Uniqure NV REGN Regeneron Pharmaceuticals RGLS Regulus Therapeutics SGMO Sangamo Therapeutics TCON TRACON Pharmaceuticals ZIOP ZIOPHARM Oncology ZYME Zymeworks . Common Stock AMGN Amgen BIIB Biogen CELG Celgene GBT Global Blood Therapeutics GILD Gilead Sciences IMMU Immunomedics INFI Infinity Pharmaceuticals IOVA Iovance Biotherapeutics MYOK MyoKardia TCRT Alaunos Therapeutics TPTX Turning Point Therapeutics ASND Ascendis Pharma AS ARCT Arcturus Therapeutics Holdings MEIP MEI Pharma SNSS Sunesis Pharmaceuticals VIRX Viracta Therapeutics IONS Ionis Pharmaceuticals VYGR Voyager Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$30

4 years 2 months 22 days ago
(01-Sep-2020)

2/8 (25%)

$14.76 (96.85%)

30

Hold

$20

$1.83 (10.07%)

$31

4 years 6 months 17 days ago
(06-May-2020)

2/4 (50%)

$0.93 (13.82%)

13

Hold

$24

$5.83 (32.09%)

$33

5 years 2 months ago
(23-Sep-2019)

4/5 (80%)

$5.96 (33.04%)

39

Hold

6 years 1 months 29 days ago
(25-Sep-2018)

2/2 (100%)

$1.2 (5.04%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jim Birchenough?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?